Pharmafile Logo
Pharmafocus logo
Advanced Search
450px-official_portrait_of_matt_hancock_crop_2

Government spend £9.2 billion on private healthcare providers for NHS in 2018-19

July 22, 2019
Sales and Marketing DHSC, NHS, UK, health, healthcare, politics, private providers

The Department of Health and Social Care paid £9.2 billion to private providers in the year prior to 31 March …

News

Ohio prosecutors file charges against opioid distributor Miami-Luken

July 22, 2019
Sales and Marketing US, USA, West Virginia, criminal case, opioid crisis, opioids

Federal prosecutors in Cincinnati have filed criminal charges against opioid distributor Miami-Luken, and four others, over the role they played …

News
mouse

Number of UK animal testing procedures falls to lowest level since 2007

July 19, 2019
Medical Communications, Research and Development Animal testing, UK, drug development, pharma, rresearch

A report from the Home Office of the UK Government has revealed that the prevalence of animal testing in the …

News
top_10_image

Top Ten most popular articles on Pharmafile.com this week!

July 19, 2019
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AMAL Therapeutics, Alzheimer's Ebola, Amgen, AstraZeneca, EMA, FDA, Novartis, pharma

On 12 July news broke that Novartis, Amgen and Banner’s Alzheimer’s Institute were discontinuing a trial into investigational compound CNP520 …

News
novartis_outside_1

A decade after US approval, Novartis’ Gilenya scores marketing authorisation in China for relapsing multiple sclerosis

July 19, 2019
Medical Communications, Sales and Marketing Novartis, gilenya, multiple sclerosis, pharma

Novartis has revealed that its disease modifying drug Gilenya (fingolimod) has secured approval in China for the treatment of relapsing …

News
congo_forest

DRC rules out trialling experimental Ebola vaccines

July 19, 2019
Medical Communications Congo, DRC, Ebola, Ebola vaccine, pharma

The Democratic Republic of Congo (DRC) has said it will stick with Merck’s rVSV-ZEBOV ebola vaccine, as it ruled out …

News

Royal Pharmaceutical Society in Scotland says contingency plans do not mitigate risk of no-deal Brexit

July 19, 2019
Medical Communications RPS, brexit, no-deal Brexit, pharma, pharmaceuticals

The Royal Pharmaceutical Society (RPS) in Scotland has raised concerns that the Government’s contingency plans do not eliminate the risks …

News
johnmchutchison3x

Dr John McHutchinson steps down from Gilead with $1.1 million goodbye

July 18, 2019
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Gilead has said that Dr John McHutchison is stepping down after nine years at the firm. Gilead’s Chief Scientific Officer …

Appointment
shutterstock_114045100

“Little to no progress” made in achieving gender representation within top pharma firms, report says

July 18, 2019
Manufacturing and Production, Medical Communications female representation, gender equality, pharma

The release of Women Count 2019, an annual report funded by The Pipeline, has revealed that “little to no progress” …

News
merckentranceweb

FDA approves MSD’s combo therapy Recarbrio for urinary tract and intra-abdominal infections

July 18, 2019
Sales and Marketing FDA, MSD, Recarbrio, US, pharma, urinary tract

MSD has announced the approval from the FDA of its combination therapy Recarbrio (imipenem, cilastatin and relebactam) in the treatment …

News
novartis_window

Novartis CEO sets aside $700 million to settle bribery lawsuit

July 18, 2019
Business Services, Sales and Marketing Novartis, bribery, lawsuit, pharma, sales

Vas Narasimhan, Novartis’ CEO, has set aside $700 million to settle a bribery lawsuit in the United States. Speaking in …

News
4108927566_c42e335fbd_z

WHO declares global public health emergency over Ebola outbreak in Congo

July 18, 2019
Medical Communications DRC, Democratic Republic of Congo, Ebola, WHO, pharma

The World Health Organization (WHO) has said the Ebola outbreak in the Democratic Republic of Congo (DRC) is a global …

News
louvre-2775455_960_720

Louvre takes down all references to Purdue-owning Sackler family

July 17, 2019
Medical Communications Art, Louvre, PR, Purdue Pharma, Sacklers, donations

The Louvre taken down references to the Sacklers, the billionaire owners of Purdue Pharma. The largest art gallery in the …

News
pixnio-drone

Autonomous drone successfully delivers temperature-controlled drugs in test programme

July 17, 2019
Research and Development, Sales and Marketing Drones, humanitarian aid, pharma

A humanitarian consortium has successfully completed a testing programme for the delivery of temperature-controlled medicines via the use of unmanned …

News

NICE greenlights Novartis Kisqali combo in HR+/HER2- advanced breast cancer

July 17, 2019
Manufacturing and Production, Medical Communications, Research and Development Cancer, Kisqali, NICE, Novartis, UK, breast cancer, pharma

Novartis’ Kisqali (ribociclib) has secured recommendation from NICE in combination with fulvestrant, meaning the cyclin-dependent kinase 4 and 6 (CDK4/6) …

News
roche

Roche signs deal with Skyhawk over molecules that modulate RNA splicing

July 17, 2019
Research and Development Genentech, Roche, Skyhawk, drug development, rna splicing

Roche’s Genentech unit has signed a deal with Massachusetts-based firm Skyhawk Therapeutics to develop and commercialise small molecules that modulate …

News
genentech_web

Genentech signs $1 billion deal with Sosei over GCPRs

July 17, 2019
Research and Development Genentech, Roche, gcprs, pharma, sosei

Roche’s Genentech has entered into a partnership with Sosei Heptares to develop small molecules and biologics that G protein-coupled receptor …

News
astrazeneca_plaque

AstraZeneca to switch entire fleet to electric vehicles by 2030

July 17, 2019
Research and Development AstraZeneca, EV100, electric vehicles, environmentalism, pharma, renewables

AstraZeneca has revealed plans to use only electric vehicles by 2030. In joining the EV100 group, AstraZeneca will transfer the …

News
Bayer image

Bayer’s Gadavist becomes first FDA-approved drug for MRI in coronary artery disease patients

July 16, 2019
Manufacturing and Production, Sales and Marketing Bayer, FDA, Gadavist, coronary artery disease, pharma

The FDA has awarded approval to Bayer’s Gadavist (gadobutrol) injection, the company confirmed.

News
shutterstock_159488225

Capricor’s share price rockets up by 150% on Phase 2 Duchenne muscular dystrophy success

July 16, 2019
Manufacturing and Production, Research and Development CAP-1002, Capricor Therapeutics, Duchenne Muscular Dystrophy, pharma

Capricor Therapeutics has unveiled impactful new Phase 2 data for its investigational allogeneic cardiosphere-derived cell therapy CAP-1002 in the treatment …

News
The Gateway to Local Adoption Series

Latest content

Complement Therapeutics’ geographic atrophy treatment receives FDA Fast Track designation

January 22, 2026

PSI appoints David Allen as Country Manager for Canada

January 22, 2026

Qureight appoints Steven Bishop as Chief Medical Officer

January 21, 2026

Pierre Fabre Laboratories and Iktos announce oncology collaboration

January 21, 2026

Qureight appoints Rebecca Simmons as Chief Operating Officer

January 20, 2026